[Role of supportive care in lung cancer].
Lung cancer is a bad prognostic illness with a limited survival and many side effects related to treatment used. Supportive care in cancer attends to enhance patient care among cancer and treatments suffering. Opioids are one of the most important treatments in the management of dyspnoea and pain. Every new drug in supportive care is tested to diminish side effects of treatment like erythropoietin against anemia or aprepitant against emesis. Many trials are developed to enhance this supportive care especially in lung cancer management.
Scotté
F
F
Service d'Oncologie Médicale, Hôpital Européen Georges-Pompidou, AP-HP, 20 Rue Leblanc, 75015 Paris, France. florian.scotte@egp.aphp.fr
Riquet
M
M
Oudard
S
S
D000465:Algorithms; D000701:Analgesics, Opioid / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use / Q000633:toxicity; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity; D000077608:Aprepitant; D002283:Carcinoma, Bronchogenic / Q000628:therapy*; D004417:Dyspnea / Q000188:drug therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D009020:Morphine / Q000009:adverse effects / Q000627:therapeutic use; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010166:Palliative Care / Q000379:methods*; D011379:Prognosis; D011994:Recombinant Proteins
D000701:Analgesics, Opioid; D020533:Angiogenesis Inhibitors; D000932:Antiemetics; D000970:Antineoplastic Agents; D009025:Morpholines; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D000077608:Aprepitant; D009020:Morphine